For the month ended 31 March 2026, EC Healthcare reported no changes in either authorised or issued share capital. Authorised share capital remained at HKD 380,000, representing 38 billion ordinary shares with a par value of HKD 0.00001 each.

Issued shares (excluding treasury shares) were unchanged at 1.19 billion, and the company confirmed compliance with the Main Board’s minimum 25 % public-float requirement. No treasury shares were held or transacted during the period.

Share-option activity was limited to the lapse of 40,000 options under the 2016 Share Option Scheme, reducing outstanding options under that plan to 18.92 million. The newer scheme approved in May 2023 maintained 59.26 million outstanding options, with no new grants, exercises, or cancellations.

No warrants, convertible securities, other share-issuance arrangements, or Hong Kong Depositary Receipts were reported. Total funds raised from option exercises during the month were HKD 0.

Overall, EC Healthcare’s capital structure and liquidity indicators remained stable throughout March 2026.